Publication Cover
Molecular Physics
An International Journal at the Interface Between Chemistry and Physics
Volume 118, 2020 - Issue 21-22: MQM 2019
185
Views
1
CrossRef citations to date
0
Altmetric
MQM 2019

Structures, electronic properties, hydration and UV-vis absorption spectra of actinide motexafins [An-Motex]2+ (An = Ac, Cm, Lr) and [UO2-Motex]1+: insights from DFT calculations

, ORCID Icon, & ORCID Icon
Article: e1736676 | Received 30 Jan 2020, Accepted 19 Feb 2020, Published online: 08 Mar 2020
 

Abstract

Molecular and electronic structures and UV-vis spectra of selected actinide(III) motexafins ([An-Motex]2+, An = Ac, Cm, Lr) as well as of uranyl(IV) motexafin ([UO2-Motex]+) were studied by using density functional theory methods combined with relativistic energy-consistent 5f-in-core actinide pseudopotentials. Solvent effects were considered by an explicit treatment of the first water coordination sphere in combination with the COSMO solvation model for bulk hydration effects. It is concluded that the Ac(III), Cm(III), Lr(III), and uranyl(IV) cations are tightly bound to the macrocyclic skeleton, yielding stable structures. By calculating the changes of the Gibbs free energies ΔG for the reactions X-Motex + Y → X + Y-Motex (X = La3+, Eu3+, Gd3+, Lu3+; Y = UO22+, Am3+, Cm3+), it is found that although in aqueous solution the Motex ligand prefers Ln3+ (Ln = Eu, Gd, Lu) over An3+ (An = Am, Cm) it rather prefers UO22+ over Ln3+ (Ln = La, Eu, Gd, Lu). The results suggest that motexafin might be useful for the separation of uranyl in nuclear waste treatments and possibly also for the treatment of uranyl poisoning in vivo. In particular motexafin might be a chelating agent for 225Ac3+ in targeted α-therapy.

GRAPHICAL ABSTRACT

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

The financial support of the Deutsche Forschungsgemeinschaft (DFG) CA 1390/1-1 is gratefully acknowledged.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.